The worth of the biobank is also determined by the data related to the samples. The biobank obviously complies with the General Data Protection Regulation (GDPR). The patient sample data are pseudonymized, meaning that patients cannot be identified, but that researchers can still access updated follow-up data that are essential for answering scientific questions. Patients are informed via an "informed consent form” (ICF) specially designed for the biobank. This ICF asks for the patient’s consent to use both the samples and the treatment and follow-up data in future research.
The scope and functioning of the biobank was approved by the GZA Medical Ethics Committee. When samples from the biobank are needed for a scientific project, approval will be sought from the Science Policy Committee and subsequently from the Ethics Committee.
The biobank of the Iridium Network is part of the Antwerp Biobank. The biobank has a documented quality system, and is now preparing for accreditation based on ISO 20387.